Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Pioglitazone Administered to Patients With Adrenomyeloneuropathy: a Phase II, Single-arm, Multicentric Clinical Trial

NCT03864523 is registered in ClinicalTrials.gov with Pujol, Aurora, M.D. as lead sponsor.

NCT NCT03864523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03864523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Pioglitazone Administered to Patients With Adrenomyeloneuropathy: a Phase II, Single-arm, Multicentric Clinical Trial
Lead sponsor
Pujol, Aurora, M.D.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2016
Completion date
July 31, 2019
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adrenomyeloneuropathy, x-linked adrenoleukodystrophy